The company posted a triple whiff, coming in under pundit projections for revenue, profitability, and top-line guidance.

AdaptHealth Corp. (NASDAQ:AHCO) reported worse-than-expected third-quarter sales and revised its FY24 net revenue guidance on ...

Leerink Partners analyst Whit Mayo has reiterated their bullish stance on AHCO stock, giving a Buy rating yesterday. Whit Mayo has given his ...

Reports Q3 revenue $805.9M, consensus $809.3M…Adjusted EBITDA was $164.3 million compared to $161.2 million, an increase of 1.9%. Suzanne ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.9%. Looking ahead, revenue ...

On Tuesday, Adapthealth Corp (AHCO) stock saw a decline, ending the day at $9.18 which represents a decrease of $-0.97 or -9.56% from the prior close of $10.15. The stock opened at $8.94 and touched a ...

AdaptHealth reported third quarter net revenue of $805.9 million compared to $804 million, an increase of 0.2% year over year.

Gary Sheehan has started a new role at AdaptHealth as general manager, senior vice president, of diabetes. “I am looking ...

AdaptHealth Corp (AHCO) reports steady revenue growth in sleep and respiratory segments, while addressing operational hurdles ...

AdaptHealth published its third-quarter results early that morning, and probably wishes it had taken a sick day for the remainder. Revenue inched up marginally on a year-over-year basis to just ...